Top compounds associated with response to ARL16


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.079 0.03
mRNA JW-7-24-1 GDSC1000 pan-cancer AAC 0.064 0.03
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.03
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC 0.073 0.04
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.072 0.04
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.07 0.04
mRNA KIN001-270 GDSC1000 pan-cancer AAC 0.072 0.04
mRNA AC55649 CTRPv2 pan-cancer AAC 0.08 0.04
mRNA TKI258 CCLE pan-cancer AAC 0.097 0.04
mRNA BRD-K01737880 CTRPv2 pan-cancer AAC 0.27 0.04
Download CSV